NCT06963489 Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
| NCT ID | NCT06963489 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital of Wannan Medical College |
| Condition | Large Vessel Occlusion |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-04-27 |
| Primary Completion | 2028-02-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-04-27 with a primary completion date of 2028-02-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter, ambispective cohort study establishes a comprehensive multiomics biobank from five stroke centers, encompassing thrombi, intracranial blood, peripheral arterial/venous blood, and clinical-laboratory-imaging-follow-up data from patients with acute ischemic stroke with large vessel occlusion (AIS-LVO).
Eligibility Criteria
Inclusion Criteria: 1. Age over 18 years. 2. Patients with intracranial and extracranial large vessel occlusion ischemic stroke confirmed by cerebrovascular angiography. 3. Availability of complete clinical and follow-up information required for the study. 4. Availability of blood and/or thrombus biological samples. 5. Voluntary written informed consent signed by the patient or their family (1) For retrospectively enrolled patients, a "broad informed consent" was signed at the time of sample collection. Upon enrollment into the cohort, a follow-up phone call was made to confirm the informed consent. (2) For prospectively enrolled patients, informed consent for this study was signed at the time of enrollment by the patient or their family. Exclusion Criteria: 1. Patients for whom biological samples cannot be obtained; 2. Patients or their family members who refuse to sign the informed consent form.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06963489 clinical trial?
This trial is open to participants of all sexes, studying Large Vessel Occlusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06963489 currently recruiting?
Yes, NCT06963489 is actively recruiting participants. Contact the research team at fzyhhz1996@gmail.com for enrollment information.
Where is the NCT06963489 trial being conducted?
This trial is being conducted at Wuhu, China, Baotou, China, Jinan, China, Henan, China and 1 additional location.
Who is sponsoring the NCT06963489 clinical trial?
NCT06963489 is sponsored by First Affiliated Hospital of Wannan Medical College. The trial plans to enroll 500 participants.